These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35570732)

  • 21. Effects of Levosimendan on Endothelial Function and Hemodynamics During Weaning From Veno-Arterial Extracorporeal Life Support.
    Sangalli F; Avalli L; Laratta M; Formica F; Maggioni E; Caruso R; Cristina Costa M; Guazzi M; Fumagalli R
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1449-1453. PubMed ID: 27495966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Levosimendan and Milrinone for ECLS Weaning in Patients After Cardiac Surgery-A Retrospective Before-and-After Study.
    Jacky A; Rudiger A; Krüger B; Wilhelm MJ; Paal S; Seifert B; Spahn DR; Bettex D
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2112-2119. PubMed ID: 29748076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan to Facilitate Weaning From Cardiorespiratory Support in Critically Ill Patients: A Meta-Analysis.
    Luo JC; Zheng WH; Meng C; Zhou H; Xu Y; Tu GW; Luo Z; Huang HB
    Front Med (Lausanne); 2021; 8():741108. PubMed ID: 34712681
    [No Abstract]   [Full Text] [Related]  

  • 24. Predicting Parameters for Successful Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock.
    Sawada K; Kawakami S; Murata S; Nishimura K; Tahara Y; Hosoda H; Nakashima T; Kataoka Y; Asaumi Y; Noguchi T; Sugimachi M; Fujita T; Kobayashi J; Yasuda S
    ESC Heart Fail; 2021 Feb; 8(1):471-480. PubMed ID: 33264500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 26. Veno-arterial extracorporeal membrane oxygenation with concomitant Impella versus concomitant intra-aortic-balloon-pump for cardiogenic shock.
    Au SY; Fong KM; Tsang CS; Chan KA; Wong CY; Ng WG; Lee KYM
    Perfusion; 2023 Jan; 38(1):51-57. PubMed ID: 34318736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
    Yang L; Ye L; Fan Y; He W; Zong Q; Zhao W; Lin R
    Eur J Pediatr; 2019 Jun; 178(6):783-793. PubMed ID: 30834480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of Survival to Discharge After Successful Weaning From Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Kim D; Na SJ; Cho YH; Chung CR; Jeon K; Suh GY; Park TK; Lee JM; Song YB; Hahn JY; Choi JH; Choi SH; Gwon HC; Ahn JH; Carriere KC; Yang JH
    Circ J; 2020 Nov; 84(12):2205-2211. PubMed ID: 33041291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weaning-Related Shock in Patients With ECMO: Incidence, Mortality, and Predisposing Factors.
    Tohme J; Piat C; Aissat N; Lebreton G; Duceau B; Charfeddine A; Baptiste A; Bouglé A
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):41-47. PubMed ID: 32828655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Veno-arterial extracorporeal membrane oxygenation for short-term mechanical circulation support in adults with cardiogenic shock: a single centre experience.
    Musiał R; Moncznik P; Śmiałek P; Stoliński J; Sadowski J; Drwiła R
    Kardiol Pol; 2016; 74(12):1477-1484. PubMed ID: 27221960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
    Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
    Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases.
    Guihaire J; Dang Van S; Rouze S; Rosier S; Roisne A; Langanay T; Corbineau H; Verhoye JP; Flécher E
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):363-369. PubMed ID: 28575211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperoxia in patients with cardiogenic shock after myocardial infarction supported with venoarterial extracorporeal membrane oxygenation.
    Ross P; Miller C; Sheldrake J; McGuiness W; Udy A; Burrell A
    Aust Crit Care; 2021 Jan; 34(1):55-59. PubMed ID: 32620254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of in-hospital mortality after successful weaning of venoarterial extracorporeal membrane oxygenation in cardiogenic shock.
    Jeong JH; Kook H; Lee SH; Joo HJ; Park JH; Hong SJ; Kim MN; Park SM; Jung JS; Yang JH; Gwon HC; Ahn CM; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee WS; Jeong JO; Park SD; Lim SH; Yu CW
    Sci Rep; 2023 Oct; 13(1):17529. PubMed ID: 37845266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmia-induced cardiomyopathy: A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.
    Hékimian G; Paulo N; Waintraub X; Bréchot N; Schmidt M; Lebreton G; Pineton de Chambrun M; Muller G; Franchineau G; Bourcier S; Nieszkowska A; Masi P; Leprince P; Combes A; Gandjbakhch E; Luyt CE
    Heart Rhythm; 2021 Jul; 18(7):1106-1112. PubMed ID: 33722763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does concurrent use of intra-aortic balloon pumps improve survival in patients with cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation?
    Wang D; Chao V; Yap KH; Tan TE
    Interact Cardiovasc Thorac Surg; 2020 Feb; 30(2):312-315. PubMed ID: 31652322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(8):1-121. PubMed ID: 32284771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors for unsuccessful weaning from venoarterial extracorporeal membrane oxygenation in patients undergoing coronary artery bypass grafting.
    Shao J; Wang L; Wang H; Hou X
    Perfusion; 2020 Oct; 35(7):598-607. PubMed ID: 31960735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant intra-aortic balloon pump and veno-arterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock.
    Arafat AA; Almedimigh AA; Algarni KD; Ismail HH; Pragliola C; Adam AI; AlBarrak M; Osman A; Albabtain MA; Tantawy TM
    Int J Artif Organs; 2023 Jun; 46(6):384-389. PubMed ID: 37125784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive-Inotropic Score as a Determinant of Timely Initiation of Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Hyun J; Kim AR; Lee SE; Hong JA; Kang PJ; Jung SH; Kim MS
    Circ J; 2022 Mar; 86(4):687-694. PubMed ID: 34759121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.